Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Christopher T. Chan(University Health Network), Klemens B. Meyer(Tufts Medical Center), Manfred Hecking(Medical University of Vienna), Thomas A. Golper, Edgar V. Lerma, Robert S. Lockridge(Western University), Daljit K. Hothi(Arbor Research Collaborative for Health), Ali K. Abu‐Alfa(Yale University), Maurizio Gallieni(University of Milan), Wolfgang C. Winkelmayer(Palo Alto University), Yoshitaka Isaka(The University of Osaka), Carol A. Pollock(The University of Sydney), Paul E. Stevens(Institute for Space Astrophysics and Planetology), Edwina A. Brown(Imperial College Healthcare NHS Trust), Rajnish Mehrotra(University of Washington), Jung Pyo Lee(Seoul National University), Vivekanand Jha(The George Institute for Global Health), Adrian Liew, Charmaine E. Lok(University Health Network), T. Alp İkizler(Vanderbilt University), Olof Heimbürger(Karolinska University Hospital), Angela Yee‐Moon Wang(Texas State University), Michael Cheung(National Kidney Foundation), Monika Lichodziejewska–Niemierko(Gdańsk Medical University), Elizabeth Lindley(Ghent University Hospital), Laura M. Dember(Boston University), Peter J. Blankestijn(Utrecht University), Hideki Kawanishi(Japanese Society for Dialysis Therapy), Jennifer E. Flythe(University of North Carolina at Chapel Hill), Ziad A. Massy(Inserm), Anthony J. Bleyer(Wake Forest University), Barnaby Hole(North Bristol NHS Trust), Csaba P. Kövesdy(University of Tennessee Health Science Center), Paul Komenda(Seven Oaks General Hospital), Linda McCann, Andrew Davenport(The Royal Free Hospital), Magdalena Madero(The University of Texas at San Antonio Health Science Center), Rafael Gómez, Peter G. Kerr(Monash Health), David C.H. Harris(The University of Sydney), Maurice Laville(Lyon 1 Université), Nathan W. Levin(Renal Research Institute), Simon Davies(Keele University), Joanne M. Bargman(University Health Network), David C. Wheeler(Roland Hill (United Kingdom)), Kunitoshi Iseki, E Lacson, Éric Goffin(Cliniques Universitaires Saint-Luc), Frederic O. Finkelstein(Yale New Haven Hospital), Takayuki Hamano(Nagoya City University)
Cited by 425
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k